Evaluation of different PCR assays for early detection of acute and relapsing brucellosis in humans in comparison with conventional methods

被引:64
作者
Mitka, Stella
Anetakis, Constantine
Souliou, Efimia
Diza, Eudoxia
Kansouzidou, Athina
机构
[1] Infect Dis Hosp, Lab Clin Microbiol, Thessaloniki 54638, Greece
[2] Aristotle Univ Thessaloniki, Sch Med, Dept Microbiol, GR-54006 Thessaloniki, Greece
关键词
D O I
10.1128/JCM.00010-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human brucellosis is a significant public health problem in many Mediterranean countries including Greece. The conventional serological methods, as well as blood cultures, have serious limitations, especially in chronic, relapsing, and focal forms of the disease. Four different PCR assays were applied in 4,926 huffy coat, whole-blood, and serum samples received from 200 patients admitted with brucellosis to the Infectious Diseases Hospital, Thessaloniki, Greece, for the rapid diagnosis of acute infection and relapses and compared to blood culture and serological tests (i.e., Wright's seroagglutination test, Coombs' antibrucella test, and the complement fixation test). The four PCR assays had excellent sensitivity and specificity and were able to detect all of the cases of acute disease. Buffy coat and whole blood were the optimal specimens. All four PCR assays were negative in all follow-up samples from 183 patients who had completed a successful treatment and were positive in all follow-up samples from 17 patients who had relapses in the first year after therapy, including the times of the relapses. In conclusion, PCR is a very useful tool for the rapid diagnosis of acute brucellosis and a good marker for the posttreatment follow-up and the early detection of relapses.
引用
收藏
页码:1211 / 1218
页数:8
相关论文
共 38 条
[1]  
ALTON G. G., 1988, TECHNIQUES BRUCELLOS
[2]   SPECIFIC ANTIBODY PROFILE IN HUMAN BRUCELLOSIS [J].
ARIZA, J ;
PELLICER, T ;
PALLARES, R ;
FOZ, A ;
GUDIOL, F .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (01) :131-140
[3]  
Ariza J, 1999, REV MED MICROBIOL, V10, P125
[4]   CHARACTERISTICS OF AND RISK-FACTORS FOR RELAPSE OF BRUCELLOSIS IN HUMANS [J].
ARIZA, J ;
CORREDOIRA, J ;
PALLARES, R ;
VILADRICH, PF ;
RUFI, G ;
PUJOL, M ;
GUDIOL, F .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) :1241-1249
[5]   Brucellosis [J].
Ariza, J .
CURRENT OPINION IN INFECTIOUS DISEASES, 1996, 9 (02) :126-131
[6]  
Armitage P., 2001, STAT METHODS MED RES, V4th
[7]  
AVHONEN P, 1969, ACTA PATHOL MIC SC, V75, P291
[8]  
BAILY GG, 1992, J TROP MED HYG, V95, P271
[9]   Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene [J].
Bardenstein, S ;
Mandelboim, M ;
Ficht, TA ;
Baum, M ;
Banai, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) :1475-1480
[10]   An IS711 element downstream of the bp26 gene is a specific marker of Brucella spp. isolated from marine mammals [J].
Cloeckaert, A ;
Grayon, M ;
Grepinet, O .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (05) :835-839